Literature DB >> 7229654

Histogenesis of demyelinating lesions in the spinal cord of guinea pigs with chronic relapsing experimental allergic encephalomyelitis.

H Lassmann, K Kitz, H M Wisniewski.   

Abstract

Spinal cord lesions in Hartley guinea pigs with chronic relapsing experimental allergic encephalomyelitis (EAE) were studied by light, transmission and scanning electron microscopy at different stages of the formation of demyelinated plaques. In addition the inflammatory response in the meninges was studied in isolated pia mater preparations separated from the spinal cord surface. In initial chronic lesions in the spinal cord, inflammation was restricted to penetrating parenchymal veins of the spinal cord and meninges. With the formation of large demyelinated plaques in the spinal cord, massive fibrosis of the meninges with infiltration by inflammatory cells was noted in an area covering the surface of the lesion. In plaques which reach the spinal cord surface, inflammatory cells could be seen passing between the pia and the spinal cord substance. In chronic remyelinated lesions, adhesions between meningeal fibroblasts and the astroglial limiting membrane were seen. In addition a topographical correlation between the distribution of spinal cord veins and venules and demyelinated plaques was found. These observations indicate that spinal cord lesions in chronic relapsing EAE are initiated by perivenous inflammation in the parenchyma and the meninges. Plaque formation, especially in spinal cord surface lesions, is additionally enhanced by the entrapment of inflammatory cells in the fibrosed meninges. The exchange of macrophages through the glia-limiting membrane may be responsible for the more rapid debris removal in the spinal cord in comparison with brain lesions in chronic relapsing EAE.

Entities:  

Mesh:

Year:  1981        PMID: 7229654     DOI: 10.1016/0022-510x(81)90046-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Structural variability of demyelinating lesions in different models of subacute and chronic experimental allergic encephalomyelitis.

Authors:  H Lassmann; K Kitz; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

2.  Inflammatory cortical demyelination in early multiple sclerosis.

Authors:  Claudia F Lucchinetti; Bogdan F G Popescu; Reem F Bunyan; Natalia M Moll; Shanu F Roemer; Hans Lassmann; Wolfgang Brück; Joseph E Parisi; Bernd W Scheithauer; Caterina Giannini; Stephen D Weigand; Jay Mandrekar; Richard M Ransohoff
Journal:  N Engl J Med       Date:  2011-12-08       Impact factor: 91.245

3.  Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice.

Authors:  Jessica Koenigsknecht-Talboo; Melanie Meyer-Luehmann; Maia Parsadanian; Monica Garcia-Alloza; Mary Beth Finn; Bradley T Hyman; Brian J Bacskai; David M Holtzman
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

4.  Cerebrospinal fluid cells in multiple sclerosis and other neurological diseases: an immunocytochemical study.

Authors:  C H Polman; C J de Groot; J C Koetsier; T Sminia; A J Veerman
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

5.  Autoimmune encephalomyelitis in rhesus monkeys induced by immunization with cerebral endothelial cell membrane.

Authors:  N Tsukada; C S Koh; N Yanagisawa; A Okano; T Taketomi
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

Review 6.  Cortical injury in multiple sclerosis; the role of the immune system.

Authors:  Caroline A Walker; Anita J Huttner; Kevin C O'Connor
Journal:  BMC Neurol       Date:  2011-12-06       Impact factor: 2.474

7.  B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.

Authors:  Heather L Wilson
Journal:  Biologics       Date:  2012-05-07

8.  Relapsing experimental allergic encephalomyelitis. An autoimmune model of multiple sclerosis.

Authors:  F D Lublin
Journal:  Springer Semin Immunopathol       Date:  1985
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.